Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
(2024, September) Retatrutide is a novel triple-agonist targeting GLP-1, GIP, and glucagon receptors, showing in phase 2 trials that it can deliver remarkably large weight losses (up to ~24% over 48 weeks in people with obesity) along with strong improvements in HbA1c, lipid profiles, liver fat (in NAFLD), insulin sensitivity, and other cardiometabolic markers
Your care team discusses formulation choice, dose optimization, and genetic insights from the Precision Peptide Genetic Test together to construct a personalized protocol matching your physiology and lifestyle
Mesoestetic Cosmelan line is used for professional care to remove dark spots and prevent their reappearance
Inpatient Treatment An inpatient treatment facility may be recommended for people with binge eating disorder
US$ 24.97
US$ 22.33
US$ 25.00
US$ 21.73
